Non-Invasive Glucose Monitoring Devices Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Non-Invasive Glucose Monitoring Devices Market: By Technology (Raman Spectroscopy, MIR/NIR (Mid/Near Infrared Spectroscopy), Optical Coherence Tomography, Occlusion Spectroscopy, Thermal Emission Spectroscopy, Impedance/Dielectric Spectroscopy, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Polarimetry), By Modality ( Wearable, Non-Wearable), By End User (Hospitals, Diagnostic centres, Home Care, Ambulatory surgical centres), By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Non-Invasive Glucose Monitoring Devices Market size was valued at USD 15 million in 2021 and expected to reach USD 94.1 million by 2028 growing at a CAGR of 30% during the forecast period 2022 to 2028. Non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players investing on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years. For example, advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient’s glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.

Non-Invasive Glucose Monitoring Devices Market

MARKET SUMMARY
-
30% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–30%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Non-Invasive Glucose Monitoring Devices Market

  • The report on global Non-Invasive Glucose Monitoring Devices Market gives historical, current, and future market sizes (US$ Mn) on the basis of technology, modality, end user and geography.
  • Non-Invasive Glucose Monitoring Devices Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Abbott Laboratories (U.S.)
  • ARKRAY, Inc. (Japan)
  • Bayer AG (Germany)
  • Dexcom, Inc. (U.S.),
  • Hoffmann-La Roche Ltd (Switzerland)
Non-Invasive Glucose Monitoring Devices Market Dynamics

Non-Invasive Glucose Monitoring Devices market is driven by high incidence of diabetes worldwide. According to WHO, prevalence of diabetes among adults over 18 years of age to have risen from 4.7% in 2012 to 8.5% by 2014. It also projects high blood glucose level and diabetes to be the 7th leading cause of death in 2030. In addition technological advancements in glucose measuring devices such as evolution of continuous glucose monitoring devices are propelling the growth of Non-Invasive Glucose Monitoring Devices market. Furthermore increase in demand for portable self-glucose measuring devices, increase in R&D investment and government funding in prevention and treatment of diabetes are expected to bolster the Non-Invasive Glucose Monitoring Devices globally


North-America Got Significant Share

Non-Invasive Glucose Monitoring Devices Market

Geographically Non-Invasive Glucose Monitoring Devices Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America expected to be major market for Non-Invasive Glucose Monitoring Devices market and growing at significant rate during forecast period. Europe region projected to show notable growth rate owing to lifestyle changes and adaptability of home care diagnosis. Asia pacific region is expected to be grow at highest rate due to grow in awareness regarding diabetes consequences such as cardiac related diseases, government and non-government organization initiatives to spread awareness in early diagnosis of diabetes, lifestyle changes and availability of patient pool.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Non-Invasive Glucose Monitoring Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Abbott Laboratories (U.S.)
  • ARKRAY, Inc. (Japan)
  • Bayer AG (Germany)
  • Dexcom, Inc. (U.S.),
  • Hoffmann-La Roche Ltd (Switzerland)
  • Johnson & Johnson (U.S.)
  • Medtronic plc (U.S.)
  • Nipro Diagnostics, Inc. (U.S.)
  • Terumo Medical Corporation (U.S.)

Description

Non-Invasive Glucose Monitoring Devices Market size was valued at USD 15 million in 2021 and expected to reach USD 94.1 million by 2028 growing at a CAGR of 30% during the forecast period 2022 to 2028. Non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players investing on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years. For example, advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient’s glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX